Galectin Therapeutics Inc. (GALT)

[biotech2010]

IMO, Management and key shareholders want $100+ for the company and, even if they were to consider a buyout, will never sell the company for under $25 a share regardless of the circumstances and until there is a positive CX trial (if there is) that valuation is ridiculous so this is a moot point.